Keywords: gsk, theravance, report, strong, ics, results, uk

GSK and Theravance report strong ICS results

Article | 23 February 2009

Print This

UK drug major GlaxoSmithKline and the USA's Theravance have reported positive results from three Phase IIb studies assessing efficacy and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in